ATE125870T1 - Hiv-spezifische monoklonale antikörper und hybridome zu ihrer herstellung. - Google Patents
Hiv-spezifische monoklonale antikörper und hybridome zu ihrer herstellung.Info
- Publication number
- ATE125870T1 ATE125870T1 AT88403036T AT88403036T ATE125870T1 AT E125870 T1 ATE125870 T1 AT E125870T1 AT 88403036 T AT88403036 T AT 88403036T AT 88403036 T AT88403036 T AT 88403036T AT E125870 T1 ATE125870 T1 AT E125870T1
- Authority
- AT
- Austria
- Prior art keywords
- monoclonal antibodies
- hiv
- hybridomas
- production
- specific monoclonal
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—RNA viruses
- C07K16/112—Retroviridae (F), e.g. leukemia viruses
- C07K16/114—Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV]
- C07K16/1145—Env proteins, e.g. gp41, gp110/120, gp160, V3, principal neutralising domain [PND] or CD4-binding site
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
- C12N5/12—Fused cells, e.g. hybridomas
- C12N5/16—Animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/176,159 US5298419A (en) | 1988-03-31 | 1988-03-31 | Human hybridomas and monoclonal antibodies which bind both gp41 and gp120 envelope proteins of human immunodeficiency virus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE125870T1 true ATE125870T1 (de) | 1995-08-15 |
Family
ID=22643233
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT88403036T ATE125870T1 (de) | 1988-03-31 | 1988-12-01 | Hiv-spezifische monoklonale antikörper und hybridome zu ihrer herstellung. |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US5298419A (de) |
| EP (1) | EP0339163B1 (de) |
| JP (2) | JPH0753755B2 (de) |
| KR (1) | KR0149848B1 (de) |
| AT (1) | ATE125870T1 (de) |
| AU (1) | AU627698B2 (de) |
| CA (1) | CA1339858C (de) |
| DE (1) | DE3854267T2 (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU9072991A (en) * | 1990-10-26 | 1992-05-26 | Public Health Research Institute Of The City Of New York, Inc., The | Neutralizing human monoclonal antibodies specific for the v3 loop and cd-4 binding site of hiv-1 gp120 |
| US6030804A (en) * | 1995-06-06 | 2000-02-29 | Human Genome Sciences, Inc. | Polynucleotides encoding G-protein parathyroid hormone receptor HLTDG74 polypeptides |
| US6197582B1 (en) | 1998-03-18 | 2001-03-06 | The Trustees Of Columbia University In The City Of New York | Development of human monoclonal antibodies and uses thereof |
| US7115262B1 (en) | 1999-03-16 | 2006-10-03 | The United States Of America As Represented By The Department Of Health And Human Services | Chimeric protein for prevention and treatment of HIV infection |
| US7060802B1 (en) * | 2000-09-18 | 2006-06-13 | The Trustees Of Columbia University In The City Of New York | Tumor-associated marker |
| JP4277490B2 (ja) * | 2001-08-27 | 2009-06-10 | セイコーエプソン株式会社 | マイクロカプセル化顔料及びその製造方法、水性分散液、並びに、インクジェット記録用インク |
| AU2006220712A1 (en) * | 2005-03-07 | 2006-09-14 | Albert Einstein College Of Medicine Of Yeshiva University | Methods of applying ionization radiation for therapy of HIV infection |
| CA2623197A1 (en) * | 2005-09-22 | 2007-03-29 | Prosci Incorporated | Glycosylated polypeptides produced in yeast mutants and methods of use thereof |
| CA2767063A1 (en) * | 2009-07-03 | 2011-01-06 | Bionor Immuno As | Novel therapeutic and diagnostic means |
| WO2017093985A1 (en) | 2015-12-05 | 2017-06-08 | Centre Hospitalier Universitaire Vaudois | Hiv binding agents |
| WO2020012435A1 (en) | 2018-07-13 | 2020-01-16 | Lausanne University Hospital | Hiv binding agents |
| JP7678790B2 (ja) | 2019-07-15 | 2025-05-16 | ローザンヌ ユニヴァーシティ ホスピタル | Hiv結合剤 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5536337Y2 (de) * | 1976-03-29 | 1980-08-27 | ||
| US4515894A (en) * | 1979-03-20 | 1985-05-07 | Ortho Pharmaceutical Corporation | Hybrid cell line for producing monoclonal antibody to human T cells |
| US4363799A (en) * | 1979-03-20 | 1982-12-14 | Ortho Pharmaceutical Corporation | Monoclonal antibody to human T cells, and methods for preparing same |
| US5087557A (en) * | 1986-06-23 | 1992-02-11 | Genetic Systems Corporation | Human monoclonal antibody to lymphadenopathy-associated virus |
| IE63109B1 (en) * | 1986-06-23 | 1995-03-22 | Genetic Systems Corp | Human monoclonal antibody to lymphadenopathy-associated virus |
| JPS6349316U (de) * | 1986-09-17 | 1988-04-04 | ||
| JPS63105619U (de) * | 1986-12-26 | 1988-07-08 |
-
1988
- 1988-03-31 US US07/176,159 patent/US5298419A/en not_active Expired - Fee Related
- 1988-11-01 AU AU24568/88A patent/AU627698B2/en not_active Ceased
- 1988-12-01 DE DE3854267T patent/DE3854267T2/de not_active Expired - Fee Related
- 1988-12-01 EP EP88403036A patent/EP0339163B1/de not_active Expired - Lifetime
- 1988-12-01 AT AT88403036T patent/ATE125870T1/de not_active IP Right Cessation
-
1989
- 1989-01-20 CA CA000588825A patent/CA1339858C/en not_active Expired - Fee Related
- 1989-03-30 KR KR1019890004086A patent/KR0149848B1/ko not_active Expired - Fee Related
- 1989-03-31 JP JP1083856A patent/JPH0753755B2/ja not_active Expired - Lifetime
-
1994
- 1994-11-24 JP JP6290097A patent/JPH07292000A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| KR0149848B1 (ko) | 1999-03-30 |
| JPH0753755B2 (ja) | 1995-06-07 |
| JPH07292000A (ja) | 1995-11-07 |
| AU2456888A (en) | 1989-10-05 |
| DE3854267D1 (de) | 1995-09-07 |
| KR890014730A (ko) | 1989-10-25 |
| US5298419A (en) | 1994-03-29 |
| AU627698B2 (en) | 1992-09-03 |
| DE3854267T2 (de) | 1996-01-04 |
| EP0339163A3 (en) | 1990-05-09 |
| JPH02219592A (ja) | 1990-09-03 |
| EP0339163A2 (de) | 1989-11-02 |
| CA1339858C (en) | 1998-05-05 |
| EP0339163B1 (de) | 1995-08-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0671920A4 (de) | Ein anti-idiotypischer antikörper und seine verwendung in der diagnose und therapie von hiv-verwandten krankheiten. | |
| IL90990A0 (en) | Pharmaceutical and diagnostic compositions containing monoclonal antibodies reactive with cachectin and a cell for the production thereof | |
| DK0807125T3 (da) | Monoklonale antistoffer mod CD6 til behandling og diagnosticering af psoriasis | |
| KR890002547A (ko) | Hiv 감염의 치료 및 진단용 모노클로날항체 및 펩티드 | |
| DE3775805D1 (de) | Arzneimittel zur behandlung periodontaler erkrankungen. | |
| ATE125870T1 (de) | Hiv-spezifische monoklonale antikörper und hybridome zu ihrer herstellung. | |
| EP0141079A3 (en) | Monoclonal antibodies specific for membrane-associated antigens | |
| DE3776133D1 (de) | Brennstoffbuendel und reaktor. | |
| IL81370A (en) | Pharmaceutical and diagnostic compositions comprising a plurality of human monoclonal antibodies for the treatment of bacterial diseases,methods for the preparation of the compositions and antibodies and kits containing said compositions | |
| ATA111789A (de) | Humaner monoklonaler antikörper und hybridom zur herstellung desselben | |
| FI944561L (fi) | HIV:tä neutraloivia monoklonaalisia yhdistelmähumaanivasta-aineita HIV-infektion ehkäisemiseksi ja hoitamiseksi | |
| DE3689868D1 (de) | Monoklonale Antikörper gegen menschliches Plasma-Prekallikrein und Verfahren zu ihrer Herstellung und Verwendung. | |
| FR2601963B1 (fr) | Heterohybridomes produisant des anticorps monoclonaux anti-rhesus d humains. | |
| FI902735A7 (fi) | Monoklonaalinen vasta-aine, joka reagoi tiettyyn laajasti erilaisissa ihmisleukemia- ja lymfomasoluissa esiintyvään antigeeniin ja menetelmä sen käyttämiseksi diagnoosiin ja hoitoon | |
| ATE103989T1 (de) | Monoklonale antikoerper gegen e7-protein des humanen papillomvirus typ 16, verfahren zu ihrer herstellung sowie ihre verwendung. | |
| FR2689518B1 (fr) | Microorganismes, procédé de préparation et utilisation. | |
| PT85278A (fr) | Procede de preparation d:une fraction immunogene active a liegard des bilharzioses et de compositions immunisantes la contenant | |
| FI883723A7 (fi) | Ihmisen monoklonaaliset vasta-aineet ja niitä vaikuttavana aineosana s isältävät terapeuttiset aineet infektiotauteja vastaan | |
| EE03170B1 (et) | Perifeerse vere mononukleaarsete rakkude tsütotoksilise aktiivsuse stimuleerimine IL-10 abil | |
| ATE207119T1 (de) | Die herstellung von menschlichen, monoklonalen antikörpern, die gegen das oberflächenantigen von hepatitis b aktiv sind | |
| DE68918229D1 (de) | Parentale Zellinien für die Herstellung von humanen Hybridomas. | |
| EP0453419A3 (en) | Use of the sp-2 monoclonal antibody for diagnostics and for monitoring of the hiv infection progress | |
| ATE84069T1 (de) | Murin-hybridoma lym-2 und diagnostikantikoerper, der dadurch hergestellt ist. | |
| NO872633L (no) | Monoklonalt antistoff mot humant plasminogen, samt fremstilling derav. | |
| RO94684A2 (ro) | Medicament pentru tratamentul unor dermatoze |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |